Qatar Fund for Development (QFFD) supports the implementation of WHO's extended 13th General Programme o...

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-23T14:10:43.374Z • Permanent link

Qatar's commitment to global health is cemented through a recent partnership with the World Health Organization (WHO), bolstering the Qatar Fund for Development's (QFFD) efforts to support the implementation of WHO's extended 13th General Programme. The QFFD has signed a Core Contribution Agreement to provide financial backing to WHO's ambitious program. Key stakeholders, including WHO Director-General Dr. Tedros Adhanom Ghebreyesus, have welcomed the partnership. By providing substantial financial support, Qatar aims to leverage its resources to drive meaningful change worldwide. Dr. Tedros has expressed his gratitude to Qatar's leaders for their unwavering commitment to global health, highlighting the significance of this partnership.

WHO's extended 13th General Programme focuses on achieving significant gains in the health of all peoples by 2030. The program's ambitious goals include universal access to healthcare, improved disease prevention, and enhanced health system resilience. Qatar's support is seen as a vital component in achieving these objectives. QFFD's contribution will be instrumental in supporting WHO's efforts to strengthen health systems, enhance healthcare workforce capacity, and improve health information systems. These initiatives are crucial in addressing pressing global health challenges, such as pandemics, infectious diseases, and non-communicable diseases.

The QFFD's partnership with WHO marks a significant milestone in Qatar's efforts to promote global health. Qatar has long been committed to advancing the health and well-being of individuals worldwide. The QFFD has been a driving force behind several high-profile health initiatives, including the establishment of the Qatar National Health Strategy 2011-2015. This strategy aimed to improve Qatar's health outcomes, enhance healthcare services, and promote a culture of health and wellness. The QFFD's partnership with WHO is a testament to Qatar's dedication to using its resources to drive meaningful change.

Qatar's commitment to global health has far-reaching implications for the Biotech & Medical domain. The QFFD's partnership with WHO will have a direct impact on research communities, healthcare markets, and policy environments. Companies involved in healthcare innovation, such as Pfizer, Johnson & Johnson, and Sanofi, will benefit from the QFFD's support. These companies are already working with WHO to develop and distribute life-saving treatments and vaccines. The QFFD's partnership will provide a significant boost to their efforts, enabling them to expand their reach and improve health outcomes worldwide.

The QFFD's support for WHO's extended 13th General Programme will also have a profound impact on research communities. Researchers at leading institutions, such as the World Health Organization's Collaborating Centres, will be able to access the QFFD's funding to conduct critical research on global health challenges. This research will be instrumental in driving innovation and advancing our understanding of complex health issues. The QFFD's partnership with WHO will also have a significant impact on healthcare markets, as companies and governments work to implement the program's ambitious goals.

Qatar's partnership with WHO is part of a larger pattern of global health initiatives. In recent years, several countries have invested heavily in global health programs, recognizing the critical role that healthcare plays in promoting economic growth, social stability, and human well-being. The QFFD's partnership with WHO is also reflective of Qatar's commitment to promoting regional cooperation and collaboration. The country has played a key role in shaping the Middle East and North Africa region's (MENA) response to global health challenges, including pandemics and infectious diseases.